DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up

Quest Diagnostics Incorporated’s (DGX) third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted figure by 3.6%.Certain one-time expenses, like the ones related to amortization expenses, certain restructuring and integration charges, other expenses and excess tax benefits associated with stock-based compensations, were excluded from the quarter’s adjusted figures.GAAP earnings came in at $1.99 per share, up 1.5% fr ...